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Infections in HIV-exposed uninfected infants:
Under-appreciated but a growing concern
M.F. Cotton
University of Stellenbosch, Cape Town, South Africa
With improving measures to prevent vertical transmission of
HIV and an expanding population of young adults acquiring HIV,
the population of HIV-exposed uninfected (HEU) infants is increas-
ing. This group is at higher risk for infectious morbidity than the
general population. Obvious reasons include a higher prevalence of
infectiousdiseases suchas tuberculosis in thehousehold and illness
in the parents affecting care & family integrity. HIV exposure, itself
might affect the immune system and formula feeding can exacer-
bate gastro-intestinal infections. Antiretroviral exposure in utero is
occasionally associated with neurodevelopmental delay.
Emerging data on infections in HEU children will be presented.
We will also discuss our own increasing awareness of this prob-
lem. The spectrum of disease can be similar to that seen in
HIV-infected children and includes Pneumocystis pneumonia and
cytomegalovirus-associated colitis.1-4
References
1. Kourtis AP, Wiener J, Kayira D, Chasela C, Ellington SR, Hyde L, Hosseinipour M,
van der Horst C, Jamieson DJ. Health outcomes of HIV-exposed uninfected African
infants. AIDS 2013;27(5):749–59.
2. Karpelowsky JS, Millar AJ, van der Graaf N, van Bogerijen G, Zar HJ. Outcome of
HIV-exposeduninfected childrenundergoing surgery.BMCpediatrics2011;11:69.
3. Slogrove AL, Cotton MF, Esser MM. Severe Infections in HIV-Exposed Unin-
fected Infants:Clinical Evidenceof Immunodeﬁciency. Journal of Tropical Pediatrics
2009;56(2):75–81.
4. Filteau S. The HIV-exposed, uninfected African child. Tropical medicine & interna-
tional health: TM & IH 2009;14(3):276–87.
http://dx.doi.org/10.1016/j.ijid.2014.03.565
Type: Invited Presentation
Final Abstract Number: 33.003
Session: Pediatric and Adolescent HIV
Date: Saturday, April 5, 2014
Time: 10:15-12:15
Room: Room 2.60
Second- and third-line treatment for pediatric
patients failing ART
C. Giaquinto
University of Padua, Padua, Italy
Recommending potent and effective second-line regimens for
infants and children is especially difﬁcult because of the current
lack of experience in resource-limited settings and the limited for-
mulations available. This highlights the importance of choosing
potent and effective ﬁrst-line regimens and ensuring their dura-
bility and effectiveness by optimizing adherence.
The 2010 WHO guidelines recommended a regimen based on a
PI boosted with RTV and combined with two NRTIs as the second-
line treatment for children who fail a regimen of two NRTIs plus
an NNRTI. For infants and young children exposed to an NNRTI
as part of PMTCT interventions and starting a PI-based regimen
in ﬁrst-line ART, the recommendation for second-line was to use
two new NRTIs and an NNRTI, as this was the only new drug class
available.
The 2013 WHO guidelines recommend as ﬁrst line therapy a
PI containing regimen. Therefore after failure of ﬁrst line children
should switch to an NNRTI based regimen including EFV if older
than 3 years of age.
Newdrugs including integrase and ﬁxed dose combination have
been introduced in the market in the developed worlds and expe-
rience on their use is growing in developing countries settings.
Validation studies to assess these new combinations are critical to
ensure future effective alternatives. Innovative second-line strate-
gies such as PI+integrase or induction and maintenance using PI/r
monotherapy among children should also be investigated.
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The emerging challenge of managing
HIV-infected adolescents
R. Ferrand
London School of Hygiene and Tropical Medicine,
London, United Kingdom
Worldwide, more than three million children are infected with
human immunodeﬁciencyvirus (HIV), approximately 90%ofwhom
live in sub-Saharan Africa. There has been a remarkable expansion
in access topaediatricARTglobally since2004, resulting in substan-
tial decline in mortality rates in HIV-infected children. As the HIV
epidemic matures, interventions to prevent mother-to-child HIV
transmission (PMTCT) and antiretroviral therapy (ART) is scaled up,
the burden of paediatric HIV infection is shifting to adolescents.
The growing population of perinatally HIV-infected adolescents
within this region presents not only unprecedented challenges,
but also opportunities to learn about managing chronic disease.
Adolescents who have grown up with HIV present signiﬁcant chal-
lenges to HIV care programmes. Some of the unique features that
characterise HIV infection in adolescence are considered. Long-
standing HIV infection acquired when the immune system is not
developed results in distinctive chronic clinical complications that
cause severe morbidity. There is limited understanding of the
pathogenesis of these conditions. As well as dealing with chronic
illness, HIV-infected adolescents have to confront psychosocial
issues, maintain adherence to drugs, and learn to negotiate sexual
relationships, while undergoing rapid physical and psychological
development. Context-speciﬁc strategies for earlier identiﬁcation
and prompt linkage to care of HIV-infected adolescents need to
be developed. Clinical HIV care should integrate age-appropriate
sexual and reproductive health, psychological, educational and
social services. Healthcare workers will need to be trained to
recognise and manage the needs of this age-group so that the
increasing numbers of children surviving to adolescence can access
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quality care beyond specialist services at lower level healthcare
facilities.
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Introductory Remarks: The role of ﬁeld actors
to successfully address the ﬁght against cholera
L. Hessel
Initiative against Diarrheal and Enteric diseases in
Africa and Asia (IDEA), Lyons, France
Despite national and international efforts, cholera continues to
represent a signiﬁcant public health burden in Asia and Africa,
now back to the Americas. The Initiative against Diarrheal and
Enteric diseases in Africa and Asia (IDEA,www.idea-initiative.info)
is a network of independent, multidisciplinary and multinational
professionals involved in enteric diseases and cholera control and
prevention from20 cholera-prone countries. Considering that joint
efforts will be more effective than individual efforts, IDEA mem-
bers are sharing information and analyzing relevant issues in order
to raise disease awareness and recommend appropriate policies
and measures to improve prevention and control of cholera and
ultimately the elimination of this scourge. Expressing a “bottom-
up” view from “the ﬁeld” through active advocacy towards local
decision and policy-makers is the way to contribute to national
and regional actions. Interdisciplinary, intersectorial and cross-
border approaches allow cross-fertilization through the sharing of
knowledge, experience and practices. It is the best way to design,
initiate and/or support relevant interventions and their effective
and sustained implementation. In January 2014 IDEAsia issued
a documented plea to all national and local policy makers to
increase awareness about the health, social and economic burden
of cholera, to support ongoing international activities towards the
improvement of disease surveillance, case management and the
introduction of oral cholera vaccine. A more comprehensive policy
brief is in progress that will propose concrete actions supporting
integrated and operational strategies at local and regional levels. It
will also advocate for the need for sustained resource allocation to
improve water and sanitation systems as the ultimate goal to elim-
inate cholera from the region. Later in 2014, the fourth meeting of
IDEAfrica will reinforce these messages to African countries.
http://dx.doi.org/10.1016/j.ijid.2014.03.568
Type: Invited Presentation
Final Abstract Number: 34.002
Session: Towards Cholera Elimination: A New Era for an Integrated
Strategy
Date: Saturday, April 5, 2014
Time: 10:15-12:15
Room: Room Roof Terrace
Genomic aspects of cholera and its relevance to
cholera control
G.B. Nair
Translational Health Science and Technology
Institute, Haryana, India
Toxigenic Vibrio cholerae belonging to serogroups O1 or O139
are water and food borne pathogens that cause the disease cholera.
The ﬁfth and sixth pandemics of cholera were caused by the clas-
sical biotype while the current seventh pandemic is caused by the
El Tor biotype, which has now completely replaced the classical
biotype. Molecular studies have further deﬁned three new variants
of El Tor V. cholerae O1 associated with cholera. The three variants
are i) the Matlab variants which could not be biotyped by conven-
tional methods since they had a combination of both classical and
El Tor traits, ii) altered El Tor O1 strains which displayed typical
traits of the El Tor biotype but carried the classical CTX prophage
and iii) altered O1 El Tor isolates which harbored ctxB of classi-
cal origin. The altered El Tor variants produce higher quantities
of cholera toxin as compared to the prototype El Tor and classi-
cal biotypes. The current pandemic caused by the El Tor biotype
has shown subtle but distinct changes in the epidemiology and
clinical presentation of the disease and also in the virulence and
molecular traits. There has also been a change in the epidemiol-
ogy of the disease with the burden of disease dominating in the
under 5 year age group particularly in cholera endemic areas of
south east Asia. Another unusual trend recently witnessed is the
protracted nature of cholera outbreaks with high case fatality. Sin-
gle nucleotide polymorphisms in 154 whole-genome sequences of
globally and temporally representative V. cholerae isolates show
that the seventh pandemic has spread from the Bay of Bengal in at
least three independent but overlapping waves, and identiﬁed sev-
eral transcontinental transmission events. From the studies on the
genomes ofV. cholerae, two facts have emerged. One is that variants
of V. cholerae O1 emerge in cholera hyper endemic areas due to the
intense transmission. The other fact is that all the three new waves
of the El Tor variants originated from the Bay of Bengal area. Taken
together, genomic studies point to the adoption of intense cholera
control programs in the cholera endemic Bay of Bengal area as a
strategy to eliminate cholera in these endemic areas and thereby
abort the emergence and spread of cholera over the region and the
globe.
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